GlassScriptPhysician profile
Justin A May
NPI 1073736682
$23,073.54
in general payments reported to CMS, 2019-2025
50 companies · $3,742 in 2025
The $3,742 reported for 2025 was more than what 79% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,710 · 2020: $1,239 · 2021: $3,136 · 2022: $3,038 · 2023: $2,757 · 2024: $3,452 · 2025: $3,742.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,319 · Travel and Lodging: $631.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,318.58 |
| Travel and Lodging | $631.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $5,256.52 | 2019-2025 | Aveir, Jot Dx, Confirm Rx |
| Medtronic Vascular, INC. | $3,093.77 | 2019-2020 | |
| Medtronic, INC. | $1,583.87 | 2021-2025 | Symplicity G3, Corevalve Evolut R, Onyx Frontier |
| Astrazeneca Pharmaceuticals LP | $1,157.71 | 2019-2025 | Farxiga, Wainua, Lokelma |
| Abiomed | $1,147.91 | 2019-2025 | Impella |
| Pfizer INC. | $969.51 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $824.08 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $820.59 | 2019-2025 | Lifevest |
| Amgen INC. | $780.35 | 2019-2025 | Repatha, Repatha |
| Boston Scientific Corporation | $776.94 | 2019-2025 | Watchman Flx, Ingevity+, General - Tachy |
| Janssen Pharmaceuticals, INC | $620.98 | 2019-2024 | Xarelto |
| Philips North America LLC | $565.90 | 2022-2025 | (Cm9) Amb Mon & Diag Und, Ambulatory Monitoring & Diagnostics Undivided |
| Boehringer Ingelheim Pharmaceuticals, INC. | $547.51 | 2019-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $388.70 | 2019-2025 | Camzyos, Eliquis |
| Merck Sharp & Dohme LLC | $386.62 | 2021-2025 | Verquvo, Capvaxive |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $383.37 | 2023-2024 | Carto 3, Qdot Micro Catheter, Octaray Mapping Catheter |
| Penumbra, INC. | $374.88 | 2020-2024 | Indigo System, Smart Coil |
| Sanofi-Aventis U.S. LLC | $354.24 | 2019-2023 | |
| Inari Medical, INC. | $315.03 | 2020-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Endologix LLC | $311.74 | 2019 | |
| Novo Nordisk INC | $270.28 | 2021-2025 | Wegovy, Ozempic, Rybelsus |
| Chiesi USA, INC. | $244.19 | 2019-2024 | Cleviprex, Kengreal |
| Regeneron Healthcare Solutions, INC. | $197.21 | 2019-2025 | Evkeeza |
| Shockwave Medical, INC | $183.00 | 2020-2021 | |
| Inspire Medical Systems, INC. | $155.89 | 2023-2025 | Inspire |
| Amarin Pharma, INC. | $143.46 | 2019-2021 | |
| Angiodynamics, INC. | $126.68 | 2024-2025 | Auryon Laser System 100-120 Vac |
| Irhythm Technologies, INC. | $115.30 | 2019-2024 | Zio Xt Patch, Zio Monitor |
| Bard Peripheral Vascular, INC. | $104.97 | 2019 | |
| Heartflow, INC. | $95.72 | 2023 | Ffrct |
| Bayer Healthcare Pharmaceuticals INC. | $78.60 | 2025 | |
| Astellas Pharma US INC | $77.65 | 2019 | |
| Impulse Dynamics (USA) INC. | $65.81 | 2022-2023 | Optimizer |
| Gilead Sciences, INC. | $61.90 | 2019 | |
| Terumo Medical Corporation | $47.15 | 2019-2024 | Glidewire |
| Atricure, INC. | $46.59 | 2021-2024 | |
| Esperion Therapeutics, INC. | $46.29 | 2021-2024 | Nexletol |
| Stryker Corporation | $43.27 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit, Flowtriever |
| Portola Pharmaceuticals, LLC | $39.51 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $39.21 | 2019-2021 | |
| W. L. Gore & Associates, INC. | $36.60 | 2021-2025 | Gore Cardioform Asd Occluder |
| Bridgebio Pharma, INC. | $30.12 | 2025 | Attruby |
| Cvrx, INC. | $29.53 | 2022-2025 | Barostim Neo System |
| Lexicon Pharmaceuticals, INC. | $27.62 | 2023-2024 | Inpefa |
| Bardy Diagnostics, INC. | $27.00 | 2022 | |
| Glaxosmithkline, LLC. | $19.68 | 2025 | Arexvy, Shingrix |
| Scpharmaceuticals INC. | $17.26 | 2024 | |
| Daiichi Sankyo INC. | $17.10 | 2019 | |
| Baxter Healthcare | $13.84 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Arbor Pharmaceuticals, INC. | $11.89 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin May listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.